Claude Franceschi: Comparing the Efficacy of CHIVA and Conventional Stripping and Ablation Techniques
Claude Franceschi, Angiologist Consultant Teacher at Center Marie‑Thérèse, shared a post on LinkedIn about a recent article by Jinghe Zhu et al, published in Annals of Vascular Surgery:
“Preserving the great saphenous vein (GSV), which is the first-choice conduit for potential future arterial grafting, is possible with CHIVA.
Systematic review and meta-analysis comparing the efficacy of CHIVA and conventional stripping and ablation techniques
Objective: Chronic venous disease (CVD), particularly primary lower extremity varicose veins, is a prevalent global health issue. The CHIVA technique is a hemodynamic-based, vein-preserving strategy proposed as a minimally invasive alternative to traditional treatments such as high ligation and stripping (HLS) or endovenous thermal ablation (e.g., radiofrequency or laser).
The CHIVA technique is designed to treat varicose veins while preserving the great saphenous vein (GSV), which is the first-choice conduit for potential future arterial grafting, especially at the infra-inguinal level. It offers theoretical advantages of reduced trauma, fewer complications, and lower recurrence potential. This systematic review aims to evaluate the efficacy and safety of CHIVA relative to established techniques based on current evidence.”
Title: Systematic Review and Meta-Analysis Comparing the Efficacy of CHIVA and Conventional Stripping and Ablation Techniques
Authors: Jinghe Zhu, Hongjie Cui, Menglong Li, Yingfeng Wu
Read the Full Article on Annals of Vascular Surgery․
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 10, 2026, 06:54Diego López Santos: Young Blood Donors Unite at the 23rd International Youth Forum in Tirana
-
Sep 10, 2026, 05:12Douglas S. Campbell: Great to See a Strong Japanese Presence in 2026 Lasker Awards
-
Sep 10, 2026, 05:11Jan Hartmann: New Transformative Treatment for Hemophilia A
-
Sep 10, 2026, 05:09Shelby Bradford: Award-Winning Science Incoming
-
Sep 9, 2026, 17:57CRISPR/Cas Gene Editing in β-Thalassemia: From Molecular Correction to Clinical Reality
-
Sep 9, 2026, 17:38Cardiovascular Health in Bleeding Disorders – EHC
-
Sep 9, 2026, 17:33Manasvi Shah: Co-Inheritance of Alpha Globin Gene Multiplication With Beta Globin Gene Abnormalities
-
Sep 9, 2026, 17:29Christina Crossette-Thambiah: One of the Largest Studies to Date in Antiphospholipid Syndrome
-
Sep 9, 2026, 17:25Alan Nurden: A miR-146a Variant Reveals a New Pathway Linking Platelet Metabolism and Thrombosis